Recreational pot revenue reached $9.8 million during the first month of 2020.
They've found a loophole in rules preventing signage.
Their stock prices could continue falling.
Why settle for less?
The company's revenue has more than doubled in just a few years.
The statement of cash flow is where you should start analyzing a company's results.
The stock has lost more than 70% of its value in the past six months.
The three big drug distributors have been in talks for months in the hopes of finding a global settlement.
The black market should have a smaller piece of the pie this year.
When it comes to cans, THC levels are likely to be lower than what's on the label.
The company already has three women's healthcare products available on the market.
These healthcare stocks can give investors a good mix of dividends and growth.
Vaping-related illnesses are likely to continue weighing on its investments in JUUL and Cronos.
For two straight months, the company's average ticket has been approximately $100.
The stock is down year to date, but a strong fourth-quarter performance could quickly turn things around.
Growth is a big question mark for both of these stocks, but for very different reasons.
The passing of the farm bill in 2018 has resulted in many companies vying for market share in the hemp industry.
They can also bring some diversity to your portfolio.
Earlier this month, the cannabis producer announced that it would be cutting 500 jobs.
Unlike its peers, the company normally posts a profit.